Early Effects of Perfluorohexyloctane Ophthalmic Solution on Patient-Reported Outcomes in Dry Eye Disease: A Prospective, Open-Label, Multicenter Study

Early Effects of Perfluorohexyloctane Ophthalmic Solution on Patient-Reported Outcomes in Dry Eye Disease: A Prospective, Open-Label, Multicenter Study

Abstract Introduction Perfluorohexyloctane ophthalmic solution (PFHO) is indicated for the treatment of signs and symptoms of dry eye disease (DED) and targets excessive tear evaporation. This study evaluated patient-reported outcomes early in treatment with PFHO. Methods This prospective, multicent...

Full description

Saved in:
Bibliographic Details
Main Authors: Jason Bacharach, Shane R. Kannarr, Anthony Verachtert, Preeya K. Gupta, Moataz Razeen, Megan E. Cavet, Jason L. Vittitow, Jacob Lang, Thomas M. Chester, Jillian F. Ziemanski, Darrell E. White
Format: Article
Language:English
Published: Adis, Springer Healthcare 2025-02-01
Series:Ophthalmology and Therapy
Subjects:
Dry eye
Patient-reported outcomes
Perfluorohexyloctane
Symptoms
Online Access:https://doi.org/10.1007/s40123-025-01097-z
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1007/s40123-025-01097-z

Similar Items